EU Reverses Course, Approves Eisai's Alzheimer's Drug After Earlier Rejection
1 month ago
In a significant shift in regulatory stance, the European Union has granted approval to Eisai Co.'s Alzheimer's treatment, marking a notable turnaround from its earlier decision to reject the drug. This development stands to impact the treatment landscape for Alzheimer’s disease and offers renewed hope for patients suffering from this debilitating condition.
Continue reading
The European Union's Ambitious Anti-Deforestation Regulation Faces Unexpected Challenges
3 months ago
A bold European Union move to stop global deforestation has run into severe difficulties that put at risk the effectiveness of its groundbreaking legislation. The Anti-Deforestation Regulation of the EU, the first in the world, is designed to reduce the level of environmental damage, yet it's plagued by a raft of operational and logistical problems.
Continue reading